RETINOBLASTOMA is a Irare inalignant tumour of embryonic retinal cells, associated with a dominantly inherited autosomal gene in one-third of cases. Although retinoblastoma is generally considered fatal without treatment, the apparent frequency of spontaneous regression may be as high as 1% (Gallie et al., 1977a) . Tn contrast, Cole (1974) reviewed the evidence for spontaneous regression in all other malignant diseases and concluded that the overall frequency was 1/80,000 OI about 1000 times less frequient than in retinoblastoma.
Two distinct clinical entities have been labelled "spontaneous regression of retinoblastoma". The first entity, of shrunken, scarred, calcified eyes (phthisis bulbi) probably results from complete intraocular ischaemic necrosis of the tumour (Andersein & Jensen, 1974) . The mechanisms leading to the second entity, nonprogressive retinal lesions in otherwise functional eyes, are less obvious. To obtain a better understanding of the biological and possible therapeutic significance of the non-progressive retinal lesions, we searched through the records of 1500 retinoblastoma patients and their relatives seen at the Harkness Eye Institute between 1961 and 1979, and identified 28 individuals who had been diagnosed as having this form of spontaneous regression of retinoblastoma; 2 more patients were seen at the Toronto clinic. Consideration of this clinical material leads us to propose the new term "retinoma" to designate these distinctive retinal lesions, highly associated with retinoblastoma but lacking malignant characteristics.
METHODS
All the individuals considered possibly to manifest spontaneous regression of retinoCorresponldence an(l reprints recluests to Dr Breid(la L. Gallie blastoma had at least one characteristic lesion of the retina, observed through a dilated pupil with an indirect ophthalmoscope. These lesions did not change on repeated examination. In addition, all patients were free of actively growing retinoblastoma and had received no radiotherapy or chemotherapy. A detailed family history was obtained from all individuals to determine whether or not any relatives had had retinoblastoma.
RESULTS
Non-progressive retinal lesions, defined by the 3 features shown in Fig. 1 (Fig. 2) shows that the lesions are supplied mainly by the retinal circulation. With repeated observation over intervals of 1-28 years (mean 10) the lesions failed to change. For the purposes of this paper, we will use the term "retinoma" to refer to these essen- (Cases 31, 128 and 233) reported in the present study have been previously described (Morris & Lapiana, 1974; Brockhurst & Donaldson, 1970; Rubin & Kaufman, 1969) . Although the present study is the largest collection of such cases, it is clear from the literature that retinomas, though rare, have been seen in many centres throughout the world for many years. The excellent clinical descriptions and frequent photographs demonstrate well the characteristics of retinomas.
Twenty-seven of the 36 previously reported cases of retinomas were associated with retinoblastoma: 8 had a family history (Morris & Lapiana, 1974; Brockhurst & Donaldson, 1970; Khodadoust et al., 1977; Smith, 1974; Merin et al., 1965; Hine, 1944) , 14 had retinoblastoma in the other eye (Smith, 1974; Fuchs, 1943; Karsgaard, 1971; Meller, 1915; Salzmann, 1921; Seuss & Stutz, 1951; Siegrist, 1912; Von Hippel, 1928; Wustenberg, 1950) and 5 had both a family history and retinoblastoma in the other eye (Smith, 1974; Purtscher, 1914; Stallard, 1936) . The remaining 9 cases of retinoma had no other evidence of retinoblastoma (Rubin & Kaufman, 1969; Smith, 1974; Boniuk & Zimmerman, 1962; Nehen, 1975; Pearce & Gillan, 1972; Sakic, 1959) . In the present study, two-thirds of the cases have either immediate family members affected by retinoblastoma, have themselves a diagnosis of retinoblastoma in the other eye, or both. The clearest proof of the association of retinomas and retinoblastoma is Case 115. Since this woman with bilateral retinomas produced 2 children with retinoblastoma by each of 2 husbands, there is little doubt that she carries the gene for the heritable form of retinoblastoma. We conclude from these data that retinomas and retinoblastoma are induced by similar genetic changes. Furthermore, we propose that multiple retinomas, or a single retinoma in the remaining eye of a unilateral retinoblastoma patient, indicate the hereditary form of retinoblastoma. This hypothesis leads to 3 predictions. First, the age at diagnosis for the unilateral retinoblastoma patients in Groups D and E should be more characteristic of bilateral hereditary retinoblastoma than of non-hereditary unilateral disease. The mean age at diagnosis of retinoblastoma in Groups D and E was 1 8 years, a value similar to that reported for bilateralretinoblastoma patients.
Second, close to 50% of the offspring of individuals in Groups B and D will develop hereditary retinoblastoma. Case 31 represents the first confirmation of this prediction. This person originally was diagnosed with bilateral retinomas in the absence of any family history of retinoblastoma and was placed in Group B. However, this individual recently produced a child who has developed multiple retinoblastoma tumours; Case 31 is now listed in Group C.
Third, on the basis of the observation that only 10% of unilaterally affected patients have the heritable form of retinoblastoma, we predict that only 10% of the individuals with a single retinoma (Group A) may produce children with retinoblastoma. All the children produced by the individuals listed in the Table will be followed to determine the validity of this prediction.
Because of the significance of the diagnosis of retinoma, it is important that the initial identification of a lesion be correct. A retinoma is characteristically a translucent, grey, retinal mass with calcified nodules and an underlying disturbance of pigment epithelium, as shown in Fig. 1 . Differential diagnosis in cases without other evidence of retinoblastoma would include larval granuloma without the usual inflammatory reaction, and astrocytic retinal hamartoma. Early astrocytic hamartomas are translucent, but later progress to a denser white appearance with many nodular areas of calcification, classically resembling a mulberry. These may be multiple and associated with systemic signs of tuberous sclerosis. Clinical differentiation of retinoma from active retinoblastoma is also critical. Indeed, retinomas very closely resemble post-irradiation regressed retinoblastoma. Actively growing retinoblastoma has a more opaque, pinkish-white appearance, in contrast to the grey, translucent appearance of retinomas.
The final differentiztion can be made, however, by serial observation. Retinomas do not progress; actively growing tumours will enlarge, spread and affect normal intraocular structures. At the first sign of enlargement, any suspicious lesions must be treated as retinoblastoma. Rychener (1948) observed malignant retinoblastoma in an eye of a 33-year-old who had been observed for retinoma; it is important that retinomas be observed periodically throughout the patient's lifetime.
The mechanisms by which retinomas arise are not known. The previous term "spontaneous regression of retinoblastoma", implied that some naturally occurring event interfered with proliferation of malignant cells, leading to decreased tumour size. Since it would be unethical to refuse treatment of an obvious tumour, it is difficult to observe regression in retinoblastoma. W'istenburg (1950) observed 2 individuals at the beginning of World War II with typical retinoblastomas; neither patient could be treated. When seen again 8 years later the lesions in both children had "regressed" and were characteristic of retinomas. These 2 cases represent the only examples, albeit partially documented, of regression of retinoblastoma, without treatment and without phthisis bulbi. Despite the lack of data documenting regression, the conventional wisdom is that retinomas arise by regression of retinoblastoma. If one considers various possible mechanisms for regression, it is difficult to find support for any of them.
Immunological mechanisms are commonly postulated in conversion of retinoblastoma into retinoma. Although Char et al. (1 974) originally reported specific cytotoxicity in the peripheral blood of patients with retinoblastoma, we have found that peripheral-blood lymphocytes from patients with retinomas had the same cytotoxicity against retinoblastoma as lymphocytes from other retinoblastoma patients and from controls (Gallie et Fig. 2 , making ischaemia unlikely.
Smith (1 974) studied microscopically 2 eyes containing untreated lesions fittinig our description of retinomas. He found only small areas of necrosis, and did not detect dividing tumour cells. He characterized the cells as "differentiated neural elements" and proposed that tumour-cell maturation was the mechanism of "regression", drawing a comparison with benign ganglioneuromatous differentiation seen in neuroblastoma. These retinomas, however, did not show the usual pattern of highly differentiatedl retinoblastoma with Flexner-Wintersteiner rosettes, Homer-Wright rosettes and fleurettes, that has been described by Tso et al. (1 970) in slow-growing radiationresistant retinoblastomas. These morphological data, showing that the only retinomas studied histologically contain differentiated elements, suggest that abnormal differentiation may produce benign nodules such as retinomas.
In this context, Knudsen & AMeadows (1980) have suggested that benign hyperplasia is often associated with heritable tumours, because the germ-line mutation itself leads to increased proliferation of certain tissue types, depending on the mutation. If any cell in the expanded hyperplastic population acquires a second mutation, they propose that that cell will become malignant. By analogy, one could propose that retinomas are benign hyperplasias resulting from a germ-line mutation affecting retinal differentiation, and that retinoblastomas are the tumours resulting from a second mutation. This model is unlikely for 2 reasons. First, although there is some histological evidence for imperfect differentiation in the nontumour retina of patients with hereditary retinoblastoma (Uga et al., 1978) , most patients have normal visual function and normal electroretinograms in successfully treated eyes. Second, retinomas are rare. Only a small proportion of asymptomatic carriers of the retinoblastoma gene develop retinomas, and when these do arise, few are seen in affected patients. If the germline mutation alone was sufficient to induce retinomas, we would expect them to occur frequently and in high numbers in affected patients.
Therefore we propose that retinomas, like retinoblastomas, require another event in addition to the germ-line mutation. This alternative explanation of retinomas is also based on Knudson's 2-mutation hypothesis (Knudson, 1971) . Since the frequency of retinoblastoma development drops rapidly after 5 years of age, the target for induction of retinoblastoma must disappear with time; otherwise individuals with retinoblastoma should appear in all age groups, with the incidence gradually increasing with age. The fact that tumours do not appear in adults implies that retinoblasts eventually differentiate into cells in which mutations or other carcinogenic events cannot lead to the development of a tumour. Presumably carcinogenic events occur at random, and may happen at any stage in the differentiation of retinoblasts. If the final mutation occurs in an immature retinoblast, it will lead to retinoblastoma. If the mutation occurs in a partially differentiated cell before terminal differentiation, it could cause abnormal proliferation leading to a hyperplastic nodule of differentiated cells; i.e., a retinoma. If the mutation occurs in a terminally differentated cell, it will have Ino effect because these cells cannot proliferate.
This explanation fits with the available clinical data on retinomas. In this model both retinoma and retinoblastoma are induced by the same series of mutations, the difference arising from the timing, in terms of embryological retinal development, of the second mutation. Retinoblast cells, capable of giving rise to retinoblastoma, are present for the first few years of life. The low frequency of retinoma compared to retinoblastoma suggests that the transition phase between retinoblast and adult retinal cell may be short.
By this model it is entirely possible for retinomas and retinoblastoma to co-exist in the same patient, though if present in the same eye the retinoblastoma would overshadow the retinoma, making its (liagnosis unlikely. The nonspecific, nonphotoreceptor type of "differentiated neurons" seen in the retinomas examined histologically by Smith (1974) would be consistent with benign proliferation of an earlv retinal cell.
